Healthcare & Life Sciences
Innovative Molecules GmbH
Germanyinnovative-molecules.com/
aliveseries-c-plus
series-c-plus
Stage
2
Investors
About
Innovative Molecules GmbH is a biotech company developing novel small molecule therapeutics. Their focus is on addressing unmet medical needs in oncology and immunology.
Explore Innovative Molecules GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.